About Index Trending news
Analyze
Pricing
Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals, Inc.

Work at Concert Pharmaceuticals, Inc.? Add yourself to this profile

Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals is a biotechnology company utilizing deuterium todevelop novel medical candidates.

Elsewhere

Contributors to this profile

Alexa global traffic share

Latest funding Show all
Post-IPO debt
$30,000,000
Hercules Capital, Inc.
Venture capital (Series C)
$37,000,000
Adage Capital Management, Flagship Ventures, Greylock Partners, +9
Employees

Team size

50+
Locations
HQ
Headquarters
$30,000,000 Post-IPO debt
businesswire , PE Hub

Concert Pharmaceuticals Announces $30 Million Venture Debt Financing from Hercules Capital

$48,500,000 Venture capital (Series B)
Added by
via PE Hub

Concert Pharma Raises $48.5 Million